• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从各个年龄段看炎症性肠病:它是同一种疾病吗?

IBD across the age spectrum: is it the same disease?

机构信息

Department of Medicine, Dr Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1069, New York, NY 10029, USA.

Gastroenterology Unit, Lille University Nord de France, CHU Lille, 2 Avenue Oscar Lambret, Lille 59 000, France.

出版信息

Nat Rev Gastroenterol Hepatol. 2014 Feb;11(2):88-98. doi: 10.1038/nrgastro.2013.240. Epub 2013 Dec 17.

DOI:10.1038/nrgastro.2013.240
PMID:24345891
Abstract

IBD is a chronic disorder with disease onset ranging from early childhood to beyond the sixth decade of life. The factors that determine the age of onset currently remain unexplained. Is timing of occurrence a random event or is it indicative of different pathophysiological pathways leading to different phenotypes across the age spectrum? Over the past decade, several studies have suggested that the characteristics and natural history of IBD seem to be different according to age of onset. This heterogeneity suggests that the respective contributions of genetics, host immune system and environment to the aetiology and phenotype of Crohn's disease and ulcerative colitis are different across ages. Critical reviews that focus on differences characterizing IBD between age groups are scarce. Therefore, this Review updates the knowledge of the differences in epidemiology, clinical characteristics, and natural history of paediatric, adult and elderly-onset IBD. In addition, potential differences in host-gene-microbial interactions according to age are highlighted.

摘要

炎症性肠病(IBD)是一种慢性疾病,发病年龄范围从儿童早期到 60 多岁以后。目前,尚不清楚决定发病年龄的因素。发病时间是随机事件,还是提示不同的病理生理途径导致了不同的表型?在过去的十年中,多项研究表明,根据发病年龄,IBD 的特征和自然病史似乎有所不同。这种异质性表明,遗传、宿主免疫系统和环境对克罗恩病和溃疡性结肠炎的发病机制和表型的各自贡献在不同年龄段是不同的。专门关注不同年龄段 IBD 特征差异的关键性评论很少。因此,本综述更新了对儿童期、成人期和老年期 IBD 的流行病学、临床特征和自然病史差异的认识。此外,还强调了根据年龄不同,宿主-基因-微生物相互作用的潜在差异。

相似文献

1
IBD across the age spectrum: is it the same disease?从各个年龄段看炎症性肠病:它是同一种疾病吗?
Nat Rev Gastroenterol Hepatol. 2014 Feb;11(2):88-98. doi: 10.1038/nrgastro.2013.240. Epub 2013 Dec 17.
2
Rapid rise in incidence of Irish paediatric inflammatory bowel disease.爱尔兰儿科炎症性肠病发病率迅速上升。
Arch Dis Child. 2012 Jul;97(7):590-4. doi: 10.1136/archdischild-2011-300651. Epub 2012 May 1.
3
The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study.德国南部农村地区炎症性肠病的发病率:一项基于人群的前瞻性研究。
Eur J Gastroenterol Hepatol. 2008 Sep;20(9):917-23. doi: 10.1097/MEG.0b013e3282f97b33.
4
Incidence and Phenotype at Diagnosis of Very-early-onset Compared with Later-onset Paediatric Inflammatory Bowel Disease: A Population-based Study [1988-2011].早发性与晚发性儿童炎症性肠病发病时的发病率和表型:基于人群的研究[1988-2011]。
J Crohns Colitis. 2017 May 1;11(5):519-526. doi: 10.1093/ecco-jcc/jjw194.
5
Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.克罗恩病和溃疡性结肠炎。欧洲一项基于人群的起始队列研究中疾病第一年的发病率、病程及预后
Dan Med J. 2014 Jan;61(1):B4778.
6
Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study).炎症性肠病发病后头五年内的诊断变化:一项前瞻性随访研究(IBSEN研究)的结果
Scand J Gastroenterol. 2006 Sep;41(9):1037-43. doi: 10.1080/00365520600554527.
7
Pediatric inflammatory bowel disease: highlighting pediatric differences in IBD.小儿炎症性肠病:突出 IBD 中的小儿差异。
Gastroenterol Clin North Am. 2009 Dec;38(4):611-28. doi: 10.1016/j.gtc.2009.07.010.
8
Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease.诊断时的表型及其他潜在预后因素对炎症性肠病病程的影响。
Am J Gastroenterol. 2009 Feb;104(2):371-83. doi: 10.1038/ajg.2008.38. Epub 2009 Jan 27.
9
Epidemiology of juvenile-onset inflammatory bowel disease in central Saudi Arabia.沙特阿拉伯中部青少年起病的炎症性肠病的流行病学
J Trop Pediatr. 2006 Feb;52(1):69-71. doi: 10.1093/tropej/fmi039. Epub 2005 Jun 9.
10
[Inflammatory disease of intestine in the child].[儿童肠道炎性疾病]
An Esp Pediatr. 1991 Dec;35(6):393-6.

引用本文的文献

1
Long-Term Effectiveness and Safety of Tofacitinib in a Nationwide Veterans Affairs Cohort of Ulcerative Colitis Patients.托法替布在全国退伍军人事务部溃疡性结肠炎患者队列中的长期有效性和安全性
Crohns Colitis 360. 2025 Jul 9;7(3):otaf037. doi: 10.1093/crocol/otaf037. eCollection 2025 Jul.
2
Human DNA levels in feces reflect gut inflammation and associate with presence of gut species in IBD patients across the age spectrum.粪便中的人类DNA水平反映肠道炎症,并与各年龄段炎症性肠病(IBD)患者肠道菌群的存在相关。
Res Sq. 2025 Jul 7:rs.3.rs-6809327. doi: 10.21203/rs.3.rs-6809327/v1.
3
Lack of children in public medical imaging data points to growing age bias in biomedical AI.
公共医学影像数据中缺乏儿童数据,这表明生物医学人工智能中年龄偏见日益严重。
medRxiv. 2025 Jun 10:2025.06.06.25328913. doi: 10.1101/2025.06.06.25328913.
4
Gut microbial Nordihydroguaiaretic acid suppresses macrophage pyroptosis to regulate epithelial homeostasis and inflammation.肠道微生物源去甲二氢愈创木酸抑制巨噬细胞焦亡以调节上皮稳态和炎症。
Gut Microbes. 2025 Dec;17(1):2518338. doi: 10.1080/19490976.2025.2518338. Epub 2025 Jul 1.
5
Exploring the Therapeutic Potential of Three Cucurbit Plants Involving In Vivo Diabetes Screening.探索三种葫芦科植物在体内糖尿病筛查中的治疗潜力。
Cureus. 2025 Feb 11;17(2):e78861. doi: 10.7759/cureus.78861. eCollection 2025 Feb.
6
Current approaches to the surgical management of Crohn's disease in Australia and New Zealand.澳大利亚和新西兰克罗恩病手术治疗的当前方法。
Int J Colorectal Dis. 2025 Jan 3;40(1):4. doi: 10.1007/s00384-024-04778-6.
7
Healthy eating patterns associated with reduced risk of inflammatory bowel disease by lowering low-grade inflammation: evidence from a large prospective cohort study.健康饮食模式通过降低低度炎症与降低炎症性肠病风险相关:一项大型前瞻性队列研究的证据
BMC Med. 2024 Dec 18;22(1):589. doi: 10.1186/s12916-024-03809-x.
8
Epidemiology of Inflammatory Bowel Disease across the Ages in the Era of Advanced Therapies.炎症性肠病在先进治疗时代的年龄分布流行病学。
J Crohns Colitis. 2024 Oct 30;18(Supplement_2):ii3-ii15. doi: 10.1093/ecco-jcc/jjae082.
9
Clinical Course of Bio Naive Ulcerative Colitis Patients Five Years After Initiation of Adalimumab in a Nationwide Cohort.在全国队列中,阿达木单抗起始治疗五年后生物制剂初治的溃疡性结肠炎患者的临床病程
Crohns Colitis 360. 2024 Aug 21;6(3):otae046. doi: 10.1093/crocol/otae046. eCollection 2024 Jul.
10
Global patterns in the epidemiology, cancer risk, and surgical implications of inflammatory bowel disease.炎症性肠病的流行病学、癌症风险及手术影响的全球模式
Gastroenterol Rep (Oxf). 2024 Jul 9;12:goae053. doi: 10.1093/gastro/goae053. eCollection 2024.